| Date | Time | Source | Headline | Symbol | Company |
| 02/10/2010 | 5:50PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/10/2010 | 1:25PM | PR Newswire (US) | MedNet Solutions Deploys Global Peripheral T-cell Lymphoma Registry for Allos Therapeutics | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/03/2010 | 8:00AM | Business Wire | Allos Therapeutics to Present at BIO CEO & Investor Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/29/2010 | 4:09PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/19/2010 | 3:53PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/12/2010 | 7:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/11/2010 | 7:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/06/2010 | 6:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/06/2010 | 8:00AM | Business Wire | Allos Therapeutics to Present at J.P. Morgan Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/04/2010 | 5:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/11/2009 | 6:25AM | Marketwired | Wall St Sense Offers In-depth Research on the Services, Financial and Healthcare Sectors' Key Players | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/08/2009 | 9:31AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/08/2009 | 9:15AM | Business Wire | Allos Therapeutics’ FOLOTYN™ Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Ly... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/07/2009 | 1:22PM | Dow Jones News | 2nd UPDATE: Celgene To Buy Gloucester Pharma for At Least $340 Million | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/07/2009 | 10:00AM | Business Wire | Allos Therapeutics’ FOLOTYN™ Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Tre... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/07/2009 | 8:41AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/05/2009 | 10:00AM | Business Wire | Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN™ at 51st ASH Annual Meeting | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/04/2009 | 8:11AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/04/2009 | 8:00AM | Business Wire | Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN™ (pralatrexate injection) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/03/2009 | 3:04PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/03/2009 | 8:00AM | Business Wire | Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematolo... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/30/2009 | 4:07PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/30/2009 | 8:00AM | Business Wire | Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/23/2009 | 6:38AM | Marketwired | Ridgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit Inc., Advanced Battery Technologies, Linn En | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/11/2009 | 8:00AM | Business Wire | Allos Therapeutics Announces New Data on FOLOTYN™ to be Presented at the American Society of Hematology Meeting | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/11/2009 | 6:54AM | Marketwired | AnalystChoice.com Provides Analytical Coverage on ELNK, NWSA, NTAP, ALTH, HANS and BPOP | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/10/2009 | 9:51AM | Business Wire | Allos Therapeutics to Present at Upcoming Conferences in November | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/03/2009 | 4:11PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/03/2009 | 4:01PM | Business Wire | Allos Therapeutics Reports Third Quarter 2009 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/02/2009 | 5:12AM | Marketwired | Global Market Perspective Review on ALTH, CINF, ALKS, DBRN, APOL and INFY from TheFortuneFinancial.com | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |